Satsuma Pharmaceuticals Correlations
| STSADelisted Stock | USD 1.10 0.01 0.90% |
The current 90-days correlation between Satsuma Pharmaceuticals and Forte Biosciences is 0.02 (i.e., Significant diversification). The correlation of Satsuma Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Satsuma Pharmaceuticals Correlation With Market
Good diversification
The correlation between Satsuma Pharmaceuticals and DJI is -0.19 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Satsuma Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
Satsuma |
Moving together with Satsuma Stock
| 0.64 | SSNLF | Samsung Electronics | PairCorr |
| 0.69 | BAC | Bank of America Aggressive Push | PairCorr |
| 0.61 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
| 0.69 | CSCO | Cisco Systems Aggressive Push | PairCorr |
Moving against Satsuma Stock
| 0.72 | PPERY | Bank Mandiri Persero | PairCorr |
| 0.72 | TLK | Telkom Indonesia Tbk | PairCorr |
| 0.72 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.7 | KO | Coca Cola Aggressive Push | PairCorr |
| 0.63 | PTAIY | Astra International Tbk | PairCorr |
| 0.6 | PPERF | Bank Mandiri Persero | PairCorr |
| 0.57 | PBCRY | Bank Central Asia | PairCorr |
| 0.56 | BKRKF | PT Bank Rakyat | PairCorr |
| 0.48 | MMM | 3M Company Fiscal Year End 28th of January 2025 | PairCorr |
| 0.46 | PFE | Pfizer Inc Aggressive Push | PairCorr |
| 0.31 | PBCRF | PT Bank Central | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Satsuma Stock performing well and Satsuma Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Satsuma Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ZIVO | 3.01 | (0.55) | 0.00 | 0.81 | 0.00 | 5.31 | 36.36 | |||
| THRX | 5.44 | (0.68) | 0.00 | (0.53) | 0.00 | 11.75 | 90.33 | |||
| ERAS | 3.24 | (0.23) | (0.03) | 0.00 | 3.67 | 7.34 | 17.38 | |||
| FBRX | 5.59 | 1.61 | 0.40 | 1.07 | 3.42 | 6.65 | 128.00 | |||
| AMTI | 5.08 | (0.09) | 0.01 | 0.08 | 5.70 | 11.11 | 36.60 | |||
| SABSW | 13.46 | 4.35 | 0.24 | (7.97) | 11.04 | 52.09 | 102.82 | |||
| SNTI | 3.18 | (0.33) | 0.00 | (1.95) | 0.00 | 7.04 | 29.17 | |||
| CING | 5.11 | (1.12) | 0.00 | (1.07) | 0.00 | 9.27 | 38.00 | |||
| BLCM | 12.36 | 0.91 | 0.06 | 0.67 | 14.01 | 23.53 | 191.61 | |||
| HILS | 5.56 | (0.78) | 0.00 | (0.34) | 0.00 | 8.33 | 113.15 |
View Satsuma Pharmaceuticals Related Equities
| Risk & Return | Correlation |
Satsuma Pharmaceuticals Corporate Management
| Robert Schultz | Manufacturing Chemistry | Profile | |
| Robert Janosky | Chief Officer | Profile | |
| John MBA | CEO Pres | Profile | |
| Detlef Albrecht | Chief Officer | Profile | |
| Mic Iwashima | VP Operations | Profile | |
| Thomas ONeil | Chief Officer | Profile | |
| Shannon Strom | VP Affairs | Profile |
Still Interested in Satsuma Pharmaceuticals?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.